Sars E2 Antibody (4A6C9)

Western Blot: Sars E2 Antibody (4A6C9) [NBP1-28850] - Western blot analysis using SARS-E2GP3 mouse mAb against SARS-E2GP3 recombinant protein.

• Reactivity: V, V
• Applications: WB, ELISA
• Clone: 4A6C9
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated

Sars E2 Antibody (4A6C9) Summary

• Description: Novus Biologicals Mouse Sars E2 Antibody (4A6C9) (NBP1-28850) is a monoclonal antibody validated for use in WB and ELISA. All Novus Biologicals antibodies are covered by our 100% guarantee.
• Immunogen: Purified recombinant fragment of Sars E2 glycoprotein precursor expressed in E. Coli.
• Predicted Species: SARS-CoV-2 (100%). Backed by our 100% Guarantee.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity: Unpurified

Applications/Dilutions

• Dilutions:
  • ELISA 1:10000
  • Western Blot 1:500-1:2000

Reactivity Notes

Immunogen displays the following percentage of sequence identity for non-tested species: COVID-19 (100%)

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: Subclonal supernatant
• Preservative: No Preservative
• Purity: Unpurified

Alternate Names for Sars E2 Antibody (4A6C9)

• COVID-19 Spike
• SARS-COV-2 S protein
• SARS-COV-2 Spike glycoprotein
• SARSCOV2 Spike protein
• SARS-E2

Background

SARS (severe acute respiratory syndrome) is caused by a human coronavirus. Human coronaviruses are the major cause of upper respiratory tract illness, such as the common cold, in humans. Coronaviruses are positive-stranded RNA viruses, featuring the largest viral RNA genomes known to date (27-31 kb). The complete sequence of the SARS virus release the coronavirus contains 25 open reading frames. SARS-E2 glycoprotein precursor is a 139-kDa glycoprotein. It contains a superantigen between residues 690 through 1050 which has relationship to T-cell Receptor alpha-beta V chain protein.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.